Keywords: 17-دماگ; 17-AAG; 17-(Allylamino)-17-demethoxygeldanamycin; 17-DMAG; 17-Dimethylaminoethylamino-17-demethoxygeldanamycin; AKT; v-akt murine thymoma viral oncogene homolog; APC; antigen presenting cell; ATM; Ataxia telangiectasia mutated; ATR; Ataxia telangiectasia
مقالات ISI 17-دماگ (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 17-دماگ; 17-DMAG; 17-dimethylamino-ethylamino-17-demethoxygeldanamycin; 4-HNE; 4-hydroxynonenal; ACC-1; acetyl-coenzyme A carboxylase 1; ACOX1; acyl coenzyme A oxidase 1; ALD; alcoholic liver disease; CPT1a; carnitine palmitoyl transferase 1a; CYP2E1; cytochrome P
Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art
Keywords: 17-دماگ; Heat shock protein 90; 17-DMAG; Cancer therapy; Inflammatory diseases;
Virtual screening and biophysical studies lead to HSP90 inhibitors
Keywords: 17-دماگ; 17-AAG; 17-allylamino-17-demethoxygeldanamycin; 17-DMAG; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG); ADP; adenosine diphosphate; AMPPCP; 5â²-adenylylmethylenediphosphonate; ASP; Astex statistical potential; ATP; adenosine triphosphat
The Hsp90 inhibitor 17-DMAG decreases infection of porcine circovirus type 2 in mice
Keywords: 17-دماگ; Antiviral; BALB/c mice; Porcine circovirus type 2; 17-DMAG;
Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4â²fluoro-phenylamino)-4H-1,3-thiazine[6,5-b]indole in A2780cis cells
Keywords: 17-دماگ; thiazine[6,5-b]indole; 2-(4â²fluoro-phenylamino)-4H-1,3-thiazine[6,5-b]indole; Hsp; heat shock protein; 17-DMAG; 17-dimethylaminoethylamino-17-demethoxygeldanamycin; 17-AAG; 17-(allylamino)-17-demethoxygeldanamycin; A2780; human ovarian adenocarcinoma ce
Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders
Keywords: 17-دماگ; 17-AAG; 17-(allylamino)-17-demethoxygeldanamycin (tanespimycin); 17-DMAG; 17- dimethylaminoethylamino-17-demethoxygeldanamycin (alvespimycin); AAV; adeno-associated virus; Aβ; amyloid-β; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; APP;
The role of the NADPH oxidase derived brain oxidative stress in the cocaine-related death associated with excited delirium: A literature review
Keywords: 17-دماگ; ExDS; Excited delirium syndrome; NADPH; Nicotinamide adenine dinucleotide phosphate; ROS; Reactive Oxygen Species; GABA; Gamma-AminoButyric Acid; HSP; Heat Shock Protein; 17-DMAG; 17-Dimethylaminoethylamino-17-demethoxygeldanamycin; NF-kB; Nuclear factor
17-DMAG induces Hsp70 and protects the auditory hair cells from kanamycin ototoxicity in vitro
Keywords: 17-دماگ; 17-DMAG; Hsp70; Kanamycin sulfate; Ototoxicity;
Molecular chaperones and neuronal proteostasis
Keywords: 17-دماگ; 17-AAG; 17-allylamino-17-demethoxygeldanamycin; 17-DMAG; 17-dimethylamino-ethylamino-17-demethoxygeldanamycin; Aβ; amyloid beta; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; ARSACS; autosomal recessive spastic ataxia of Charlevoix-Saguena
In silico investigations on HSP90 and its inhibition for the therapeutic prevention of breast cancer
Keywords: 17-دماگ; HSP90; Homology modeling; Protein-protein docking; Protein-ligand docking; 17-DMAG;
ER homeostasis and motility of NSCLC cell lines can be therapeutically targeted with combined Hsp90 and HDAC inhibitors
Keywords: 17-دماگ; 17-DMAG; ER stress; Lung cancer; PTACH; Unfolded protein response; ER homeostasis
The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor
Keywords: 17-دماگ; Hsp90; Hsp90 inhibitor; 17-DMAG; Gefitinib; EGFR mutation; EGFR-TKI; Acquired resistance
Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation
Keywords: 17-دماگ; Hsp90; heat shock protein 90; HCV; hepatitis C virus; RdRp; RNA-dependent RNA polymerase; 17-DMAG; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin; PDK1; phosphoinositide-dependent kinase-1; PRK2; protein kinase C-related kinase 2; Hsp90 inhibitor;
Blocking the chaperone kinome pathway: Mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors
Keywords: 17-دماگ; Chaperone; Hsp90; 17-DMAG; Withania somnifera; Withaferin A;
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
Keywords: 17-دماگ; Clinical trial; Phase I; 17-DMAG; Hsp90;
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β
Keywords: 17-دماگ; minocycline; 17-DMAG; (+)-naloxone; nonstereoselective; allodynia; hyperalgesiaaCSF, artificial CSF; AP-1, activator protein 1; BL, baseline; ELISA, enzyme-linked immunosorbent assay; HEK-TLR4, HEK 293 cells stably transfected with TLR4 and the co-recepto
Determination of the heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin in plasma by liquid chromatography–electrospray mass spectrometry
Keywords: 17-دماگ; 17-DMAG; LC/MS; Plasma; Pharmacokinetics; Cancer
Generation of a novel anti-geldanamycin antibody
Keywords: 17-دماگ; Geldanamycin; Herbimycin A; 17-AAG; 17-DMAG; Antibody; Benzoquinone ansamycins; HSP90;
Structure-based design of 7-carbamate analogs of geldanamycin
Keywords: 17-دماگ; Geldanamycin; Hsp90; 17-AAG; 17-DMAG; Structure-based design
17-Allyamino-17-demethoxygeldanamycin and 17-NN-dimethyl ethylene diamine-geldanamycin have cytotoxic activity against multiple gynecologic cancer cell types
Keywords: 17-دماگ; HSP90; AKT; 17-AAG; 17-DMAG; Endometrial cancer; Molecular therapeutics;